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Abstract
Titanium dioxide (TiO2) nanoparticles are one of the most highly manufactured and
employed nanomaterials in the world with applications in copious industrial and consumer
products. The liver is a major accumulation site for many nanoparticles, including TiO2,
directly through intentional exposure or indirectly through unintentional ingestion via water,
food or animals and increased environmental contamination. Growing concerns over the
current usage of TiO2 coupled with the lack of mechanistic understanding of its potential
health risk is the motivation for this study. Here we determined the toxic effect of three differ-
ent TiO2 nanoparticles (commercially available rutile, anatase and P25) on primary rat
hepatocytes. Specifically, we evaluated events related to hepatocyte functions and mito-
chondrial dynamics: (1) urea and albumin synthesis using colorimetric and ELISA assays,
respectively; (2) redox signaling mechanisms by measuring reactive oxygen species (ROS)
production, manganese superoxide dismutase (MnSOD) activity and mitochondrial mem-
brane potential (MMP); (3) OPA1 and Mfn-1 expression that mediates the mitochondrial
dynamics by PCR; and (4) mitochondrial morphology by MitoTracker Green FM staining. All
three TiO2 nanoparticles induced a significant loss (p < 0.05) in hepatocyte functions even
at concentrations as low as 50 ppm with commercially used P25 causing maximum dam-
age. TiO2 nanoparticles induced a strong oxidative stress in primary hepatocytes. TiO2
nanoparticles exposure also resulted in morphological changes in mitochondria and sub-
stantial loss in the fusion process, thus impairing the mitochondrial dynamics. Although this
study demonstrated that TiO2 nanoparticles exposure resulted in substantial damage to pri-
mary hepatocytes, more in vitro and in vivo studies are required to determine the complete
toxicological mechanism in primary hepatocytes and subsequently liver function.
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Introduction
Engineered nanoparticles form a major fraction of man-made nanomaterials currently escalat-
ing in both development and commercial implementation [1]. Among the engineered nanoma-
terial, titanium dioxide (TiO2) nanoparticles are one of the most highly manufactured in the
world and are widely used in paints, printing ink, paper, cosmetics, pharmaceuticals, sun-
screen, bio-medical ceramic and implanted biomaterials, industrial photocatalytic processes
and decomposing organic matters in wastewater [2–5]. Concerns regarding the potential health
risks of these nanoparticles have been raised due to their inherent physicochemical attributes
such as small size, increased surface area, conductivity and aggregation potential. Studies on
the bio-distribution of TiO2 nanoparticles have indicated the liver as one of the principal sites
in the body for accumulation through intentional ingestion or indirectly through nanoparticle
dissolution from food containers or secondary ingestion of inhaled particles [6, 7]. Addition-
ally, increased environmental contamination and unintentional ingestion via water, food or
animals may also result in subsequent accumulation of nanoparticles in the liver [8–10]. The
concern about adverse health effects of low-level exposure to TiO2 is imperative to address,
particularly to analyze whether TiO2 exposure causes damage to mitochondrial bioenergetics
and the liver. Although there is a plethora of published literature on acute TiO2 toxicity, the
effect of TiO2 exposure on the hepatocyte mitochondria and its implications on the liver biol-
ogy remains to be investigated. The current knowledge in the field of hepatotoxic effects of
TiO2 nanoparticles is not yet exhaustive, and further investigation is necessary to fully elucidate
the pathogenesis of the liver damage and the potential relationship between liver toxicity and
the different characteristics of nanoparticles. Interestingly, the interactions between TiO2
nanoparticles and DNA, both direct and indirect, such as those mediated by oxidative stress,
deserve greater attention in order to understand their potential role in the mechanisms under-
lining genotoxic and carcinogenic effects.
The liver is a multicellular organ that performs numerous vital metabolic, synthetic and
clearance-related functions in mammals [11]. Hepatocytes account for approximately 80% of
the liver mass and exhibit high metabolic and biotransforming activity that consequently
imposes high energy requirements and is regulated by the high density of mitochondria, dis-
tributed uniformly throughout the cell body [12, 13]. Mitochondria acts as the vital source of
energy in hepatocytes and also play an important role in extensive oxidative metabolism and
normal functioning of the liver [14]. Inherently, mitochondria have an extremely dynamic
nature; they undergo continual fission and fusion processes that counterbalance each other, to
alter the organelle morphology that enables the cell to meet its metabolic requirements and
cope with internal or external stress [15, 16]. Three central players that control the process of
mitochondrial fission and fusion resulting in the unique structural features have been identified
in mammals: (1) Mitofusins 1 and 2 (Mfn-1 and Mfn-2); for outer-membrane fusion (2)
OPA1; for inner membrane fusion and (3) Drp1 for inner and outer membrane fission [16]. In
normal conditions, mitochondrial fusion enhances mitochondrial integrity by allowing com-
ponent sharing across the tubular network. However, the fusion of highly damaged mitochon-
dria to the network could be detrimental since impaired mitochondria generate reactive
oxygen species (ROS) that results in substantial cellular damage [14, 16]. Numerous environ-
mental factors can also lead to excess ROS production and oxidative stress. Damage to mito-
chondrial dynamics and biology has been demonstrated to be a vital factor in several liver
disorders [12, 17–21]. Functional impairment of mitochondria in hepatocytes due to oxidative
stress is often accompanied by modification of mitochondrial proteins, DNA and lipid peroxi-
dation which may lead to mitochondrial bioenergetics failure, that eventually leads to compro-
mise in cellular functions and subsequent necrotic or apoptotic cell death [22]. Diminished
Titanium Dioxide Nanoparticles and Hepatocytes
PLOS ONE | DOI:10.1371/journal.pone.0134541 August 6, 2015 2 / 19
OPA1 and Mfn (1 and 2) levels have been reported in biological systems that are in a diseased
state [23, 24]. Sebastian et al. reported that a liver-specific knockout of Mfn-2 protein resulted
in disrupted glucose metabolism in the liver, forming a potential cause for type II diabetes [25].
Recent studies have demonstrated that exposure to several engineered materials, including
nanomaterials, leads to structural and functional alterations in mitochondrial membranes [26,
27]. Thus, studies on understanding the effect of nanoparticles exposure on liver function and
mitochondrial biology is the need of the hour in order to address the implications of nanoparti-
cles exposure on potential liver diseases but is very limited in the literature.
In this study, we investigated the perturbations in the liver behavior and mitochondrial
characteristics caused by exposure to TiO2 nanoparticles on primary hepatocytes isolated from
rat liver. We utilized three commercially employed TiO2 nanoparticles (P25, Anatase, and
Rutile), to investigate nanoparticle specific perturbation in an explicit range of concentrations
mimicking TiO2 nanoparticle accumulation. Additionally, we evaluated the effect of TiO2
nanoparticles exposure on mitochondrial health and oxidative stress as indicators of perturba-
tions in normal liver function. These findings are the first step towards broadening our under-
standing on the molecular mechanisms of liver dysfunction induced by these highly utilized
nanoparticles. Our findings also demonstrate detrimental effects of TiO2 nanoparticles on cel-
lular and mitochondrial function in primary hepatocytes and suggest that mitochondrial stress
can be used as an early and potent diagnostic marker for nanotoxicological inquiries in the
liver.
Materials and Methods
Preparation of TiO2 nanoparticle suspensions
Degussa P25 (particle size 21 nm) was obtained from Sigma Aldrich, St. Louis, MO. Pure rutile
(particle size 50 nm), and pure anatase (particle size 50 nm) were purchased fromMK Nano,
Mississauga, Ontario, Canada. The nanoparticles were UV sterilized and stock suspensions
were made in sterile Phosphate Buffer Saline (PBS) at pH 7.4 and sonicated [FS30D Fisher Sci-
entific] for 30 min and stored in dark at 4°C until use.
Isolation, Culture and Treatment of Primary Hepatocytes
All the animal procedures were carried out in accordance with the guidelines from IACUC of
University of Nebraska-Lincoln. Primary rat hepatocytes were isolated from male Sprague-
Dawley rats weighing 160-200g through a two-step collagenase perfusion technique adapted
from P.O Seglen [28]. Around 150–200 million cells were obtained at a viability greater than
85% as confirmed by Trypan blue dye exclusion test. Before seeding, tissue culture plate sur-
faces were coated with 100 μg/ml rat tail collagen type I solution prepared in 0.02N acetic acid
for 1 hour at 37°C, washed and stored at 4°C until use. Cells were seeded at a density of
100,000/cm2 on the collagen coated plates. Nanoparticle suspensions in the desired concentra-
tions were prepared in the culture media and added to the cells.
Primary Hepatocyte Culture medium
Culture medium was prepared with high glucose DMEM supplemented with 10% fetal bovine
serum, 0.5 U/ml insulin, 20 ng/ml epidermal growth factor (EGF), 7 ng/ml glucagon, 7.5 mg/
ml hydrocortisone, and 1% penicillin-streptomycin. All the constituents for the cell culture
medium was obtained from Sigma Aldrich, USA.
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Dynamic Light Scattering Particle Sizing and Zeta Potential
Measurement
TiO2 Nanoparticle size and zeta potential were measured using a NanoBrook ZetaPALS zeta
potential and dynamic light scattering instrument [Brookhaven instrument, Holtsville, NY].
Desired concentrations of nanoparticle suspensions were prepared by dilution with Hepatocyte
culture medium. Mean hydrodynamic diameter was measured at a scattering angle of 90°, and
the Zeta potential was calculated fromMobility measurements by using the Smoluchowski
model. All measurements were performed at 25°C at a pH of 7.4.
Scanning Electron Microscopy
Nanoparticle size and shape were assessed and viewed under a scanning electron microscope
(SEM) [S-3000N, Hitachi Tokyo, Japan]. Cellular morphology and nanoparticle distribution
were visualized by SEM. The cells were rinsed with PBS and fixed with 4% paraformaldehyde/
PBS solution for 15 min. The paraformaldehyde solution was removed, samples rinsed with
PBS and dehydrated with ethanol solutions (from 20 to 100%). The sample was incubated for
15 min at room temperature in each solution. The 100% ethanol solution was removed with
hexamethyl disilazane [Sigma Aldrich, USA], and the sample was allowed to air-dry. The sam-
ples were then coated with gold-palladium (Au-Pd) and analyzed under the SEM.
Lethal Concentration (LC50) Assessment using MTT Assay
The cytotoxicity of nanoparticles was assessed by MTT assay [3-(4,5-dimethyldiazol-2-yl)2,5
diphenyl Tetrazolium Bromide] [Life Technologies, NY] which quantitatively evaluates the
mitochondrial conversion of the MTT salt into purple formazan crystals. Nanoparticle solution
was removed, and 0.5 mg/ml MTT working solution in DMEM was incubated on live cells at
37°C for 2.5 h. After incubation, the working solution was removed, and lysis buffer (0.1 N
HCl in Isopropanol) added. The lysis buffer was transferred to a 96 well plate and absorbance
values collected in an AD340 plate reader [Beckman Coulter, Brea, CA] at corrected 570/620
nm. Relative absorbance was used as the indicator of cell viability. Concentration range of
0 ppm to 1000 ppm for each nanoparticle was used to generate the dose-response curve. Sigma-
Plot software was used to calculate LC50 value for each type of nanoparticle. Data were
expressed as the means ± SD from three independent experiments.
Urea Assay
Urea secretion by hepatocytes in culture medium was assessed every 24 h using Stanbio Urea
Nitrogen (BUN) kit [Stanbio, Boerne, TX] using manufacturer’s protocol. Briefly, the kit
exploits the reaction between urea and diacetyl monoxime which results in a color change at an
absorbance of 520 nm read on AD 340 plate spectrophotometer [Beckman Coulter, Brea, CA].
Data were expressed as the means ± SD from six independent experiments.
Albumin ELISA
Albumin Secretion by hepatocytes into culture medium was measured every 24 h using Rat
Albumin ELISA Quantitation Kit from Bethyl Laboratories, Inc [Montgomery, TX] according
to manufacturer’s instructions. In short, a 96 well plate was coated with a coating antibody for
1 hour and blocked with BSA for 30 min. Standard/Sample was added to each well and incu-
bated for 1 hour. HRP detection antibody was incubated for 1 hour, followed by the addition of
TMB Substrate solution that was developed in the dark for 15 min. Absorbance was read on
Titanium Dioxide Nanoparticles and Hepatocytes
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AD340 plate spectrophotometer [Beckman Coulter, Brea, CA] at 450 nm. Data were expressed
as the means ± SD from six independent experiments.
Live/Dead Assay
Cell viability was assessed using a Live/Dead Viability/Cytotoxicity Kit [L-3224 Invitrogen,
Grand Island, NY]. Briefly, post-treatment, primary hepatocytes were washed with PBS and
incubated at 37°C for 30 min with assay reagent (4 μM EthD-1 and 2 μMCalcein in PBS) at
37°C. The cells were removed and washed three times with PBS and viewed with an Axiovert
40 CFL [Zeiss, Germany] and X-Cite 120Q [Lumin Dynamics, Mississauga, Ontario, Canada].
Transmission Electron Microscopy (TEM)
Stable suspensions of the different nanoparticles were prepared in DI water using sonication.
The samples were prepared for imaging by sequential drying steps on copper grids [Ted Pella
Inc., CA] that were coated with carbon. Hitachi H7500 TEM was used for analyzing the
samples.
Reactive Oxygen Species (ROS) Quantification
Reactive Oxygen Species (ROS) production was quantified by an H2DCFDA based fluores-
cence assay. Briefly, the cells were washed to remove traces of serum from the culture media
and were incubated with 10μMH2DCFDA [Life Technologies, NY] for a duration of 30 min at
37°C. After incubation, cells were gently washed, and cells were trypsinized using TRYPLE
select [Life Technologies, NY] and suspended in PBS. The cell suspension was transferred to a
96 well plate, which was read at excitation 528 nm and emission 405 nm using a SLFA plate
reader [Biotek, Winooski, VT]. Hydrogen Peroxide treatment was used as a positive control,
and the untreated hepatocytes were used as the experimental control to normalize the fluores-
cence intensity. Data were expressed as the means ± SD from four independent experiments.
Each experiment was carried out with three experimental replicates.
Gene Expression
At each time point, total RNA from primary hepatocytes was isolated using RNeasy Micro Kit
[Qiagen, Valencia, CA] according to the manufacturer’s instructions. Briefly, cells were trypsi-
nized, centrifuge pelleted, washed with PBS and lysed in RLT buffer with equal volume 70%
ethanol. The mix was then centrifuged in an RNeasy spin column, washed and concentrated
until the final RNA was released into RNase-free water. The quality and quantity was deter-
mined by ND-1000 spectrophotometer [NanoDrop Technologies Wilmington, DE]. Equal
amount of total RNA (1 μg) from each sample (treated and untreated) was reverse transcribed
using iScript cDNA synthesis kit [Bio-Rad Laboratories, CA] by following manufacturer’s
instructions.
Quantitative Real-Time PCR was performed using SYBR Green Master Mix [Applied Bio-
systems, Foster City, CA] in an epgradient S Mastercycler [Eppendorf, NY]. The primers of
interest were obtained from Integrated DNA Technologies [Coralville, IA] with the following
sequences: OPA-1 (Forward 5’- CCTGTGAAGTCTGCCAATCC -3' and Reverse 5’-
CTGGAAGATGGTGATGGGTT -3'), Mfn1 (Forward 5’-TCGTGCTGGCAAAGAAGG-3’ and
Reverse 5’-CGATCAAGTTCCGGGTTCC-3’). GAPDH (Forward 5’ ATGATTCTACC
CACGGCAAG 3’ and Reverse 5’ CTGGAAGATGGTGATGGGTT 3’) was used as the house-
keeping gene. A single PCR product formation was monitored using the SYBR green compati-
ble melting curve analysis. Double normalization was carried out with respect to total RNA
Titanium Dioxide Nanoparticles and Hepatocytes
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and the housekeeping gene and the relative gene expression levels of the target genes were
reported using the ΔΔCT method of analysis. Data were expressed as the means ± SD from
three independent experiments. Each experiment was carried out with three experimental
replicates.
Mitochondrial Morphology Imaging
Mitotracker FM, green stain [Life Technologies, NY] was used for the specific staining of pri-
mary hepatocyte mitochondria. Live cells were washed with PBS, and the dye was diluted to a
concentration of 100 nM in Fluorobrite DMEM [Life Technologies, NY] and added to the
cells. Cells were incubated at 37°C for 45 min and then washed extensively and imaged using
confocal microscopy (Olympus FV500 IX 81).
Mitochondrial Membrane Potential (MMP) Assay
MMP of primary hepatocytes was determined using Tetramethylrhodamine (TMRM) [Life
Technologies, NY] staining. TMRM is a cationic dye that selectively stains healthy mitochon-
dria that are depolarized. A working solution of concentration 50 nM was prepared in Fluoro-
brite DMEM and added to the cells. The cells were incubated in the dark at room temperature
for 45 minutes, following which, the cells were washed 3X with PBS. Cells were trypsinized
using TRYPLE select [Life technologies, NY] and resuspended in Fluorobrite DMEM. The
fluorescence of the cells was recorded through flow cytometry using a FACSCantoll from Bec-
ton Dickenson [Franklin Lakes, NJ]. The cell suspensions were transferred to flow cytometry
tubes and samples were analyzed for fluorescence in the red channel (excitation 573 nm and
emission 590 nm). The fold change in the cell staining for the untreated and treated cells, rela-
tive to the unstained hepatocytes, was reported. Data were expressed as the means ± SD from
three independent experiments.
Manganese Superoxide Dismutase (MnSOD) Enzyme Activity Assay (In
Gel)
MnSOD enzyme activity of primary hepatocytes was measured using a gel assay. Protein was
collected from cells post treatment using RIPA buffer with PMSF and protease inhibitors.
Total protein quantity was determined using Bradford assay. Total of 30 μg protein was loaded
onto 10% native Tris-Glycine polyacrylamide gels, and polyacrylamide gel electrophoresis
(PAGE) was carried out in non-denaturing conditions to ensure intact MnSOD enzyme activ-
ity. The gel was then incubated in the dark in a staining solution containing 0.1 mg/ml ribofla-
vin, 0.1mg/ml nitroblue tetrazolium (NBT) and 1μl/ml TEMED. The gel was washed with DI
water and exposed to light. The superoxide released by TEMED interacts with NBT converting
it into purple formazan. This turns the gel purple except in the area of the gel with MnSOD,
which scavenges the superoxide giving rise to colorless bands. The gels were analyzed using the
imaging system of Odyssey by LI-COR followed by the imaging software Image Studio. Data
were expressed as the means ± SD from three independent experiments.
Statistical Analysis
Data were expressed as the mean ± SD from three independent experiments. The difference
between the various experimental groups was analyzed by a one-way analysis of variance
(ANOVA) using the statistical analysis embedded in SigmaPlot Software using Tukey test. Q
tests were employed to identify outliers in the data subsets. For statistical analysis of all data,
p< 0.05 was used as the threshold for significance.
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Results
TiO2 Nanoparticle Characterization
TiO2 nanoparticles were first characterized using TEM and DLS. TEM was utilized to examine
the individual crystal shapes and sizes of the different TiO2 nanoparticles (Fig 1). Anatase TiO2
nanoparticles revealed the characteristic spherical crystal structure, and rutile nanoparticles
displayed a typical rod-like crystal structure. Both particles displayed a size of approximately
50 nm. P25, which is a 3:1 mixture of anatase and rutile. These results were in agreement with
the manufacturer’s specifications and previous reports on the characterization of the shape of
the nanoparticles.[6, 29, 30].
The nanoparticle suspensions were then characterized for the hydrodynamic diameter of
the aggregates formed and the zeta potential in the media environment that is exposed to the
cells using DLS. The working concentration of nanoparticles suspensions were prepared in
hepatocyte media to recreate the cell culture conditions to identify the forms in which the
nanoparticles are exposed to the cells. As shown in Table 1, P25, anatase, and rutile nanoparti-
cles aggregated to average diameter of approximately 800 nm, 700 nm, and 380 nm, respec-
tively, and this aggregation was consistent in all the studied nanoparticle concentrations. Zeta
potential were also measured for the three TiO2 nanoparticles (Table 1). The zeta potential val-
ues did not change significantly (p> 0.05) in the three forms of the nanoparticles and
concentrations.
TiO2 Nanoparticles Cytotoxicity to Primary Hepatocytes
We evaluated the cytotoxicity of three different TiO2 nanoparticles (P25, anatase, and rutile)
using MTT assay. A 72 h exposure to the three different TiO2 nanoparticles of varying concen-
tration (0–1000 ppm) to primary hepatocytes established the LC50 value corresponding to the
different treatment, as determined by constructing a dose-response curve. As seen in Table 2,
the LC50 values of P25, anatase and rutile TiO2 nanoparticles were 74.13±9.72 ppm, 58.35
±4.76 ppm, and 106.81±11.24 ppm, respectively. S1 Fig represents the dose-response curves
plotted for the different nanoparticles using non-linear regression.
TiO2 Nanoparticle and Hepatocytes Morphology
We studied the effect of nanoparticle treatment on the cellular morphology using SEM (Fig 2).
After 72 h of exposure to the three chosen concentrations of the nanoparticles, primary hepato-
cytes did not exhibit a marked change in cellular morphology. For all three nanoparticles, we
observed the smooth and spherical morphology of hepatocytes that was comparable to
untreated cells.
TiO2 Nanoparticle and Hepatocytes Viability
We quantified the viability loss in hepatocytes using MTT assay. The exposure of hepatocytes
to TiO2 nanoparticles showed a concentration and type dependent loss in viability (Fig 3).
When normalized with respect to untreated hepatocyte samples, in P25 treatment, 84% cells
were viable when exposed to 20 ppm concentration that decreased to 75% at 100 ppm concen-
tration. Similarly in hepatocytes exposed to anatase nanoparticles, the cell viability decreased
substantially from 85% in the 20 ppm concentration to 66% in 100 ppm. In rutile treatment,
the loss in viability was concentration dependent but demonstrated the least severity, where the
cell viability was approximately 80% in the 100 ppm treated samples. In addition to the MTT
assay, S2 Fig also provides qualitative analysis of the loss in cell viability in primary hepatocytes
when exposed to the different nanoparticles.
Titanium Dioxide Nanoparticles and Hepatocytes
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TiO2 Nanoparticle and Loss in Hepatocyte Functions
We studied the effect of prolonged exposure of hepatocytes to TiO2 nanoparticles on two main
hepatocyte specific functions- urea synthesis and albumin synthesis. As seen in Fig 4A, we
observed a consistent concentration and type dependent loss in urea synthesis function. For
every million hepatocytes, the exposure of hepatocytes to 50 ppm of P25 resulted in 105.6
±19 μg/ml urea synthesis, as opposed to 178 ± 20.9 μg/ml synthesis in untreated hepatocytes.
Similarly, the exposure of hepatocytes to 50 ppm of anatase resulted in 127.9±21.6 μg/ml urea
synthesis. Finally, the exposure of hepatocytes to rutile resulted in 134.7±6.9 μg/ml urea syn-
thesis, which was relatively higher as compared to the 50 ppm treatment group of other
particles.
Similarly, Fig 4B illustrates the albumin synthesis of primary hepatocytes after 72 h of expo-
sure to different TiO2 nanoparticles. We observed a concentration and type dependent loss in
albumin synthesis comparable to our data on urea production. For each million hepatocytes,
the exposure to 50 ppm of P25 resulted in 3.5±0.8 μg/ml albumin production, as compared to
untreated hepatocytes that synthesized 5.3±0.69 μg/ml albumin. The exposure of hepatocytes
Fig 1. Transmission Electron Microscopy images to characterize the crystal shape of the TiO2 nanoparticles as seen in DI water; (a) P25, (b)
Anatase, 50 nm particle size and (c) Rutile, 50 nm particle size.
doi:10.1371/journal.pone.0134541.g001
Table 1. Characterization of TiO2 nanoparticles aggregates forming in hepatocyte culture medium using Dynamic Light Scattering (DLS) at 37°C
and pH of 7.4.
TiO2 Nanoparticle Concentration (ppm) Hydrodynamic Diameter (nm) Polydispersity Index Zeta Potential (mV)
P 25 20 841.7 ± 85.3 0.279 -10.8 ± 2.5
50 783.5 ± 85.3 0.157 -8.7 ± 3.5
100 784.1 ± 54.5 0.226 -6.4 ± 2.4
Anatase 20 739.1 ± 86.9 0.232 -8.7 ± 4.3
50 659.2 ± 35.0 0.166 -7.4 ± 2.8
100 692.4 ± 59.4 0.178 -9.9 ± 4.3
Rutile 20 380.0 ± 29.1 0.236 -10.2 ± 1.8
50 374.8 ± 34.5 0.189 -8.5 ± 4.6
100 396.3 ± 13.5 0.248 -6.5 ± 4.3
doi:10.1371/journal.pone.0134541.t001
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to 50 ppm of anatase resulted in 4.22±0.8 μg/ml albumin production. Finally, in the case of
rutile treatment, the exposure of hepatocytes to 50 ppm resulted in 4.5±0.3 μg/ml albumin pro-
duction. The comprehensive quantification of urea synthesis and albumin synthesis by hepato-
cytes cultured for a week demonstrated similar trend when exposed to the different
concentrations of the TiO2 nanoparticles (S3 Fig).
TiO2 Nanoparticle Effect on Oxidative stress and Mitochondrial
Dynamics
We quantified the ROS production using H2DCFDA dye in order to measure the increased
oxidized status of the cells in response to nanoparticles exposure (Fig 5A). At a median concen-
tration of 50 ppm, a type dependent increase in ROS production was observed when primary
hepatocytes were exposed to TiO2 nanoparticles. The exposure of hepatocytes to 50 ppm of
P25 and anatase resulted in relatively highest ROS production while exposure to the same con-
centration of rutile demonstrated lesser ROS production.
We studied the effect of TiO2 nanoparticle treatment on mitochondrial MnSOD enzyme
activity (Fig 5B) and observed that the enzyme activity significantly decreased in each of the
treatment groups (P< 0.05). As compared to untreated hepatocytes at 100%, P25 treated sam-
ples displayed 50.5±20.1% enzyme activity, followed by anatase at 67±18.2% and rutile at 86
±13.8% enzyme activity. We also probed for the effect of the nanoparticle treatment on the
MMP of hepatocytes (Fig 5C) and observed that the treatment leads to significant loss in
MMP, as compared to untreated cells (p< 0.05).
TiO2 Nanoparticle Effect on Mitochondrial Dynamics
To understand the effect of nanoparticle treatment on mitochondrial dynamics, we investi-
gated the relative gene expressions of OPA-1 and Mfn-1 markers that are associated with mito-
chondrial fusion events (Fig 6A and 6B). OPA-1 and Mfn-1 gene expression levels were
significantly down-regulated in hepatocytes when exposed to 50 ppm P25 and anatase with
commercially used P25 having the highest effect (p< 0.05). Down-regulation of the fusion
markers in rutile treatment group was the least pronounced, as compared to anatase and P25.
To probe and visualize the effect of the nanoparticles on the mitochondrial morphology and
integrity, we imaged the mitochondria using the fluorescent stain Mitotracker FM (Fig 6). The
untreated primary hepatocytes depicted the typical fiber-like morphology indicating healthy
mitochondria. When hepatocytes were exposed to TiO2 nanoparticles, there was a substantial
loss in the fiber-like morphology and presence of high levels of fragmentation was also
observed.
Discussion
The liver is the major accumulation site for many nanoparticles, however, the toxicological
effects of the nanoparticles on the liver function have not been extensively investigated.
Table 2. Lethal Concentration (LC50) analysis of the different TiO2 nanoparticles treatment of primary
rat hepatocytes.
Nanoparticle Type LC50 value (in ppm)
P 25 74.13 ± 9.72
Anatase 58.35 ± 4.76
Rutile 106.81 ±11.24
doi:10.1371/journal.pone.0134541.t002
Titanium Dioxide Nanoparticles and Hepatocytes
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Numerous in vitro liver models have been developed during the last two decades to supplement
animal studies [31–38]. A major weakness of existing literature about the in vitro effects of
nanoparticles is that the in vivo dosimetry and biokinetics are largely ignored, i.e., effects, if
observed, are at high concentrations [39, 40]. A majority of the in vitro nanoparticle liver toxic-
ity studies have extensively used cell lines. Several studies demonstrate that primary hepato-
cytes are a better in vitromodel compared to cell lines such as HepG2 cells for cytotoxicity
Fig 2. Scanning Electron Microscopy (SEM) images to visualize the morphology of primary hepatocytes when treated with TiO2 nanoparticles
after 72 h of exposure. Scale bar: 30 microns. Yellow arrows point to primary hepatocytes.
doi:10.1371/journal.pone.0134541.g002
Fig 3. MTT assay to quantify primary hepatocyte viability after treatment with different TiO2
nanoparticles at 20, 50 and 100 ppm after 72 h of exposure normalized to the untreated hepatocytes.
The values are the mean ± SD of five different samples, significant difference with respect to control is
denoted as * p value < 0.001.
doi:10.1371/journal.pone.0134541.g003
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Fig 4. Characterizing the effect of the different TiO2 nanoparticles treatment (50 ppm) on primary
hepatocytes specific functions (A) Quantification of urea synthesized primary hepatocytes after 72 h
of exposure normalized to the untreated cells and (B) Quantification of albumin synthesized by
primary hepatocytes after 72 h of exposure normalized to the untreated cells. The values are
normalized with respect to loss in cell viability. The values are the mean ± SD of six different samples,
significant difference with respect to control is denoted as * p value < 0.001, # p value< 0.05.
doi:10.1371/journal.pone.0134541.g004
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Fig 5. Characterizing the state of oxidative stress in primary hepatocytes upon TiO2 nanoparticle treatment at a concentration of 50 ppm for a
duration of 72 h (A) Quantification of Reactive Oxygen Species produced using H2DCFDA based fluorescence assay (B) In gel mitochondrial
MnSOD enzyme activity assay normalized with respect to untreated cells (C) Fold change in the TMRM staining to quantify mitochondrial
membrane potential using flow cytometry reported relative to the unstained cells. The values are the mean ± SD of four different samples, significant
difference with respect to control is denoted as * p value < 0.001, # p value< 0.05.
doi:10.1371/journal.pone.0134541.g005
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Fig 6. Characterization of the effect of TiO2 nanoparticle treatment (50 ppm) for duration of 72 h on primary hepatocyte mitochondrial dynamics.
(A-B) Relative gene expressions of mitochondrial fusion markers through qPCR using double normalization with respect to total RNA and housekeeping
gene (GAPDH). The values are the mean ± SD of four different samples, significant difference with respect to control is denoted as * p value < 0.001, # p
value< 0.05. (C) Fluorescent imaging of the mitochondrial morphology in primary rat hepatocytes using Mitotracker green FM. Scale 20 microns. In the
control image, long fiber-like mitochondrial morphology can be observed, as compared to fragmented and swollen mitochondria as seen in nanoparticle
treated samples.
doi:10.1371/journal.pone.0134541.g006
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studies due to the inherent differences in the bio-transformation potential of cell lines vs. pri-
mary cells. Wang and co-workers demonstrated that hepatic cell lines depict different behavior
with respect to metabolism mediated liver toxicants when compared to primary hepatocytes
[41]. Harris and co-workers showed that primary hepatocytes are a preferred model when
studying genotoxicity or carcinogenicity because the cell lines do not represent the exact
genome of the target tissue they are modeling [42]. Studies have utilized liver-specific cell lines
to demonstrate cytotoxicity effects of nanoparticles on liver [43, 44]. However, these studies
are limited to common cytotoxicity end points such as MMP, glutathione, ROS and lactate
dehydrogenase and do not address the impact of nanoparticle exposure on liver-specific func-
tions such as urea or albumin synthesis and mitochondrial integrity. Our study utilizing pri-
mary hepatocytes provides a better in vitro model to study the impact of nanoparticle exposure
on hepatocyte function and mitochondrial damage. Primary hepatocyte culture is a robust
platform to study cytotoxicity effects in the liver compared to animal models. Xu and co-work-
ers demonstrated a decrease in Blood Urea Nitrogen (BUN) levels (in vivo equivalent to urea
synthesis) when mice were exposed to TiO2 nanoparticles [45]. Wang et al have also demon-
strated a loss in mice liver functions through assessment of the liver enzymes and BUN when
exposed to TiO2 nanoparticles [46]. Our studies utilizing primary hepatocytes demonstrate
similar trends in liver specific functions when exposed to TiO2 nanoparticles as observed in
animal studies. Our cytotoxicity studies indicated that pure anatase and P25 nanoparticles are
more cytotoxic compared to rutile nanoparticles and this observation is consistent with previ-
ous reports comparing the anatase and rutile TiO2 nanoparticles [29].
The purpose of our study was to further probe the effect of TiO2 nanoparticles on primary
hepatocytes focusing on the changes in cellular function and mitochondrial dynamics. Numer-
ous studies have consistently used high concentrations of the nanoparticles, thus limiting these
studies to probe mechanistic aspects beyond the toxicity of the nanoparticles. Sha et al demon-
strated the effect of TiO2 nanoparticles on BRL-3A cell lines (concentrations of 0.1 to 100 μg/
ml) and the liver of rat models (concentrations of 0.5–50 mg kg−1) where oxidative stress medi-
ated toxicity was observed in both models [47]. Kermanizadeh and co-workers reported the
occurrence of genotoxicity of TiO2 nanoparticles (0.5–256 μg/ml) in C3A cells [48]. Our study
provided us with the range of concentrations (20, 50 and 100 ppm) with 72 h exposures that is
reflective of the LC50 data. These concentrations fall in the sub-lethal range, thereby permitting
us to investigate crucial early cellular events, which facilitated a better mechanistic understand-
ing of the intrinsic factors mediating nanoparticle induced toxicity. Our results also indicated
that there is a concentration and type dependent effect on primary hepatocytes when exposed
to TiO2 nanoparticles. This difference in the cell behavior reflects on potentially different
modes of actions from the different TiO2 nanoparticles on the hepatic biology. We also demon-
strated a concentration and type dependent loss in urea and albumin synthesis function of
hepatocytes. The most critical observation is the exposure to 100 ppm of commercially used
P25 TiO2 nanoparticles for 72 h, though has 80% viable cells, results in an over 45% loss in
hepatic functions. This indicated that employing cell viability as a sole marker for the effect of
environment exposures including nanoparticles is a weak biomarker to identify potential risk
factors of these exposures.
Numerous studies have demonstrated that metal oxide nanoparticle induced toxicity is pri-
marily mediated by increased ROS production [49, 50]. We also demonstrated that TiO2 nano-
particle exposure in primary hepatocytes results in increased ROS production. We further
showed that primary hepatocytes, when exposed to TiO2 nanoparticles, resulted in a loss in
MnSOD enzyme activity and MMP. Cells possess a robust anti-oxidant mechanism to cope
with and prevent the downstream damage from excess ROS. MnSOD scavenger enzymes are
the first line of the antioxidant defense system protecting the cells from potential damage
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caused by excessive amounts of ROS by scavenging the superoxide radicals [51]. MnSOD is the
prominent isomer of the enzyme that is abundant in the mitochondria and contributes to the
maintenance of redox homeostasis inside mitochondria [51]. Our observation that the nano-
particle exposure significantly reduces the MnSOD enzyme activity is a strong indication that
the antioxidant system is impaired, leading to potential irreversible damage to the cell, espe-
cially mitochondria [52]. We also observed significant loss in MMP in primary hepatocytes
when exposed to all three nanoparticles. The maintenance of MMP in the mitochondria is criti-
cal for proper oxidative phosphorylation function to occur and is therefore considered a critical
marker to evaluate mitochondrial perturbation [53, 54]. Decrease in the MMP leads to more
ROS production in the mitochondria, thus contributing to further mitochondrial membrane
damage. The fluctuations in MMP is considered as Tier 3 oxidative stress responses and can
lead to apoptotic responses [53]. These data strengthens our hypothesis that exposure to nano-
particles results in substantial mitochondrial damage in primary hepatocytes and the increase
in the ROS levels is not due to adaptive response.
Mitochondria are extremely dynamic in nature and undergo continual fission and fusion
processes to alter the morphology that enables the cell to meet its metabolic requirements and
cope with internal or external stress. OPA1 andMfn-1 are markers known to be instrumental in
regulating the fusion process in maintaining the mitochondrial dynamics. We observed a signif-
icant down-regulation in the gene expression levels of OPA1 andMfn-1 in the 50 ppm treated
hepatocytes, whereas, this down-regulation was not significant in the rutile treated cells
(p> 0.05). The exposure to nanoparticles also resulted in a substantial loss in the fiber-like mor-
phology and increase in fragmentation. Braydich-Stolle and co-workers showed similar effect
due to TiO2 nanoparticle treatment on keratinocytes that resulted in localization and causative
damage of the mitochondria [55]. Hepatocytes possess a unique mitochondrial organization
wherein the mitochondria are spread throughout the cell body unlike other cells where the mito-
chondria are concentrated around the cell nuclei and concentration decreases radially. Loss in
the typical fiber-like morphology and increase in fragmentation is a strong indication of com-
promise in the mitochondria dynamics. This is in agreement with our observation where OPA-
1 andMfn-1 were significantly downregulated in hepatocytes exposed to TiO2 nanoparticles.
This defect in mitochondrial fusion results in mitochondria that appear swollen and spherical,
instead of fiber-like. Together, these results indicate that exposure to TiO2 nanoparticles even at
a concentration as low as 50 ppm results in significant mitochondrial damage by interrupting
the fusion-fission equilibrium and affecting the mitochondrial dynamics [56].
Overall, we observed that the exposure of primary rat hepatocytes to different types of com-
mercially available TiO2 nanoparticles causes significant compromise in hepatocyte function
and mitochondrial biology. Even though we observed a modest loss in cell viability, hepatic
specific functions, urea and albumin synthesis, are significantly reduced due to TiO2 nanoparti-
cles exposure at concentrations as low as 50 ppm. We observed an increase in the amount of
intracellular ROS production due to exposure to TiO2 nanoparticles. A decrease in the enzyme
activity of MnSOD demonstrated compromise in the antioxidant defense mechanism and irre-
versible oxidative damage. Loss in mitochondrial membrane potential demonstrated the loss in
mitochondrial oxidative phosphorylation function. Finally, we observed that the exposure to
TiO2 nanoparticles resulted in significant down-regulation of OPA1 and Mfn-1 genes and frag-
mented mitochondrial network in hepatocytes that is a strong indicator of the disruption of the
mitochondrial dynamics. From these observations, we propose that TiO2 nanoparticles induce
cytotoxicity of hepatocytes by (1) down-regulating the fusion process thus disrupting the mito-
chondrial dynamics and inducing damage to the mitochondrial morphology, (2) triggering oxi-
dative stress mediated by an increase in ROS production, loss in MMP and loss in MnSOD
enzyme activity and (4) inducing loss in hepatic functions including urea and albumin (Fig 7).
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Therefore, we hypothesize that TiO2 nanoparticles could potentially contribute to subsequent
adverse health effects and the development of liver diseases such as liver fibrosis. Future work
is underway focusing on how these nanoparticle induced compromise of the mitochondrial
dynamics in hepatocytes leads to liver damage and other potential liver diseases.
Supporting Information
S1 Fig. Dose response curve to calculate LC50 using four parameter plots for the different
titanium dioxide nanoparticle treatment on primary hepatocytes.
(TIF)
S2 Fig. Live/Dead fluorescent staining of primary hepatocytes when treated with titanium
dioxide nanoparticles on Day 7 in culture. Calcein FM stains the live cells green and Ethid-
ium Bromide stains the dead cells red. Scale bar: 100 microns.
(TIF)
S3 Fig. (A) Quantification of urea synthesized primary hepatocytes from day 1 to day 7 in
culture when treated with the different TiO2 nanoparticles and (B) Quantification of albu-
min synthesized by primary hepatocytes when treated with the different TiO2 nanoparti-
cles. All the data points are normalized to untreated hepatocytes.
(TIF)
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Supporting Information
S1 Fig. Dose response curve to calculate LC50 using four parameter plots for the different titanium dioxide nanoparticle 
treatment on primary hepatocytes.
(TIF)
S2 Fig. Live/Dead fluorescent staining of primary hepatocytes when treated with titanium dioxide nanoparticles on Day 7 
in culture. Calcein FM stains the live cells green and Ethidium Bromide stains the dead cells red. Scale bar: 100 microns.
(TIF)
S3 Fig. (A) Quantification of urea synthesized primary hepatocytes from day 1 to day 7 in culture when treated with the 
different TiO2 nanoparticles and (B) Quantification of albumin synthesized by primary hepatocytes when treated with the 
different TiO2 nanoparticles. All the data points are normalized to untreated hepatocytes.
(TIF)
